Skip to main content
logo
ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.600
+0.030 (1.91%)
Jun 12, 2026, 9:00 AM CET

STO:EXPRS2 Revenue

ExpreS2ion Biotech Holding AB had revenue of 6.87M SEK in the quarter ending March 31, 2026, with 132.26% growth. This brings the company's revenue in the last twelve months to 16.12M, up 74.74% year-over-year. In the year 2025, ExpreS2ion Biotech Holding AB had annual revenue of 12.21M with 56.00% growth.

Revenue (ttm)
16.12M
Revenue Growth
+74.74%
P/S Ratio
0.34
Revenue / Employee
848.32K
Employees
19
Market Cap
5.54M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202512.21M4.38M56.00%
Dec 31, 20247.83M-974.00K-11.07%
Dec 31, 20238.80M2.65M43.07%
Dec 31, 20226.15M-7.58M-55.21%
Dec 31, 202113.73M-1.53M-10.04%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Magle Chemoswed Holding AB273.25M
Alzinova AB25.66M
Fluicell AB20.15M
Spago Nanomedical AB4.38M
Aptahem AB2.52M
Biosergen AB2.09M
2cureX AB1.98M
Pila Pharma AB1.13M
Revenue Rankings

ExpreS2ion Biotech Holding AB News

More News